BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med 2018;20:1122-30. [PMID: 29446766 DOI: 10.1038/gim.2017.247] [Cited by in Crossref: 197] [Cited by in F6Publishing: 171] [Article Influence: 49.3] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol 2021;6:19. [PMID: 33824923 DOI: 10.21037/tgh-20-109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Olde Keizer RACM, Henneman L, Ploos van Amstel JK, Vissers LELM, Frederix GWJ. Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy. J Med Econ 2021;24:60-70. [PMID: 34915793 DOI: 10.1080/13696998.2021.2009725] [Reference Citation Analysis]
3 Pinto D, Schmitt F. Current applications of molecular testing on body cavity fluids. Diagn Cytopathol 2020;48:840-51. [PMID: 32227635 DOI: 10.1002/dc.24410] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
4 Reuter CM, Kohler JN, Bonner D, Zastrow D, Fernandez L, Dries A, Marwaha S, Davidson J, Brokamp E, Herzog M, Hong J, Macnamara E, Rosenfeld JA, Schoch K, Spillmann R, Loscalzo J, Krier J, Stoler J, Sweetser D, Palmer CGS, Phillips JA, Shashi V, Adams DA, Yang Y, Ashley EA, Fisher PG, Mulvihill JJ, Bernstein JA, Wheeler MT; Undiagnosed Diseases Network. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing. J Genet Couns 2019;28:1107-18. [PMID: 31478310 DOI: 10.1002/jgc4.1161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
5 Kowdley DS, Kowdley KV. Appropriate Clinical Genetic Testing of Hemochromatosis Type 2-4, Including Ferroportin Disease. Appl Clin Genet 2021;14:353-61. [PMID: 34413666 DOI: 10.2147/TACG.S269622] [Reference Citation Analysis]
6 Hays T, Wapner RJ. Genetic testing for unexplained perinatal disorders. Curr Opin Pediatr 2021;33:195-202. [PMID: 33605625 DOI: 10.1097/MOP.0000000000000999] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gardner EJ, Sifrim A, Lindsay SJ, Prigmore E, Rajan D, Danecek P, Gallone G, Eberhardt RY, Martin HC, Wright CF, FitzPatrick DR, Firth HV, Hurles ME. Detecting cryptic clinically relevant structural variation in exome-sequencing data increases diagnostic yield for developmental disorders. Am J Hum Genet 2021;108:2186-94. [PMID: 34626536 DOI: 10.1016/j.ajhg.2021.09.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Irum S, Naz K, Ullah N, Mustafa Z, Ali A, Arslan M, Khalid K, Andleeb S. Antimicrobial Resistance and Genomic Characterization of Six New Sequence Types in Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates from Pakistan. Antibiotics (Basel) 2021;10:1386. [PMID: 34827324 DOI: 10.3390/antibiotics10111386] [Reference Citation Analysis]
9 Chen M, Chen J, Wang C, Chen F, Xie Y, Li Y, Li N, Wang J, Zhang VW, Chen D. Clinical application of medical exome sequencing for prenatal diagnosis of fetal structural anomalies. Eur J Obstet Gynecol Reprod Biol 2020;251:119-24. [PMID: 32502767 DOI: 10.1016/j.ejogrb.2020.04.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Minari J, Brothers KB, Morrison M. Tensions in ethics and policy created by National Precision Medicine Programs. Hum Genomics 2018;12:22. [PMID: 29665847 DOI: 10.1186/s40246-018-0151-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
11 Lee N, Park MJ, Song W, Jeon K, Jeong S. Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer. Int J Mol Sci 2020;21:E8807. [PMID: 33233830 DOI: 10.3390/ijms21228807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Afzal M, Alghamdi SS, Migdadi HH, Khan MA, Nurmansyah, Mirza SB, El-Harty E. Legume genomics and transcriptomics: From classic breeding to modern technologies. Saudi J Biol Sci 2020;27:543-55. [PMID: 31889880 DOI: 10.1016/j.sjbs.2019.11.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
13 Li G, Wang G, Guo Y, Li S, Zhang Y, Li J, Peng B. Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma. World J Surg Oncol 2020;18:249. [PMID: 32950055 DOI: 10.1186/s12957-020-02025-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhou‐tsang A, Wu Y, Henderson S, Walker A, Borneman A, Walker R, Gilliham M. Grapevine salt tolerance. Australian Journal of Grape and Wine Research 2021;27:149-68. [DOI: 10.1111/ajgw.12487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Wordsworth S, Doble B, Payne K, Buchanan J, Marshall DA, McCabe C, Regier DA. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions. Value Health 2018;21:1048-53. [PMID: 30224108 DOI: 10.1016/j.jval.2018.06.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
16 Katragadda S, Hall TO, Bettadapura R, Dalton JC, Ganapathy A, Ghana P, Hariharan R, Janakiraman A, Kotha KBVSSP, Manjunath A, Mannan AU, Ms N, Saraf S, Tzeng KTH, Veeramachaneni V. Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing. Clin Chem 2021;67:1122-32. [PMID: 34120169 DOI: 10.1093/clinchem/hvab059] [Reference Citation Analysis]
17 Mairi A, Touati A, Lavigne JP. Methicillin-Resistant Staphylococcus aureus ST80 Clone: A Systematic Review. Toxins (Basel) 2020;12:E119. [PMID: 32075074 DOI: 10.3390/toxins12020119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
18 Norris S, Belcher A, Howard K, Ward RL. Evaluating genetic and genomic tests for heritable conditions in Australia: lessons learnt from health technology assessments. J Community Genet 2021. [PMID: 34570356 DOI: 10.1007/s12687-021-00551-2] [Reference Citation Analysis]
19 Buchanan J, Blair E, Thomson KL, Ormondroyd E, Watkins H, Taylor JC, Wordsworth S. Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease. Eur J Hum Genet 2019;27:1639-48. [PMID: 31186546 DOI: 10.1038/s41431-019-0452-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
20 Fahr P, Buchanan J, Wordsworth S. A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine. Appl Health Econ Health Policy 2019;17:443-52. [PMID: 30941659 DOI: 10.1007/s40258-019-00474-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
21 Long M, Register-Brown K. Autism Spectrum Disorder. Pediatr Rev 2021;42:360-74. [PMID: 34210755 DOI: 10.1542/pir.2020-000547] [Reference Citation Analysis]
22 Nabbout R, Kuchenbuch M. Impact of predictive, preventive and precision medicine strategies in epilepsy. Nat Rev Neurol 2020;16:674-88. [PMID: 33077944 DOI: 10.1038/s41582-020-0409-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
23 Crawford SA, Gong CL, Yieh L, Randolph LM, Hay JW. Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care. Genet Med 2021. [PMID: 34040192 DOI: 10.1038/s41436-021-01210-0] [Reference Citation Analysis]
24 Bai Y, Wang G, Wei J, Dai C, Xu X, Cai X, Wu B, Sun W, Xu Q, Jiao S. Using clinical genomic sequencing to guide personalized cancer therapy in China. Per Med 2019;16:287-99. [PMID: 30895868 DOI: 10.2217/pme-2018-0056] [Reference Citation Analysis]
25 Shickh S, Clausen M, Mighton C, Gutierrez Salazar M, Zakoor KR, Kodida R, Reble E, Elser C, Eisen A, Panchal S, Aronson M, Graham T, Armel SR, Morel CF, Fattouh R, Glogowski E, Schrader KA, Hamilton JG, Offit K, Robson M, Carroll JC, Isaranuwatchai W, Kim RH, Lerner-Ellis J, Thorpe KE, Laupacis A, Bombard Y; Incidental Genomics Study Team. Health outcomes, utility and costs of returning incidental results from genomic sequencing in a Canadian cancer population: protocol for a mixed-methods randomised controlled trial. BMJ Open 2019;9:e031092. [PMID: 31594892 DOI: 10.1136/bmjopen-2019-031092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
26 Griesemer I, Staley BS, Lightfoot AF, Bain L, Byrd D, Conway C, Grant TL, Leach B, Milko L, Mollison L, Porter N, Reid S, Smith G, Waltz M, Berg JS, Rini C, O'Daniel JM. Engaging community stakeholders in research on best practices for clinical genomic sequencing. Per Med 2020;17:435-44. [PMID: 33026293 DOI: 10.2217/pme-2020-0074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Gilson P. Enrichment and Analysis of ctDNA. Recent Results Cancer Res. 2020;215:181-211. [PMID: 31605230 DOI: 10.1007/978-3-030-26439-0_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Jayasinghe K, Wu Y, Stark Z, Kerr PG, Mallett AJ, Gaff C, Martyn M, Goranitis I, Quinlan C. Cost-Effectiveness of Targeted Exome Analysis as a Diagnostic Test in Glomerular Diseases. Kidney Int Rep 2021;6:2850-61. [PMID: 34805637 DOI: 10.1016/j.ekir.2021.08.028] [Reference Citation Analysis]
29 Katsantoni E. Omics Studies in Hemoglobinopathies. Mol Diagn Ther 2019;23:223-34. [PMID: 30712217 DOI: 10.1007/s40291-019-00386-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
30 Cai Z, Poulos RC, Liu J, Zhong Q. Machine learning for multi-omics data integration in cancer. iScience 2022;25:103798. [PMID: 35169688 DOI: 10.1016/j.isci.2022.103798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
31 Campuzano O, Sarquella-Brugada G, Arbelo E, Cesar S, Jordà P, Pérez-Serra A, Toro R, Brugada J, Brugada R. Genetic Variants as Sudden-Death Risk Markers in Inherited Arrhythmogenic Syndromes: Personalized Genetic Interpretation. J Clin Med 2020;9:E1866. [PMID: 32549272 DOI: 10.3390/jcm9061866] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
32 Aaltio J, Hyttinen V, Kortelainen M, Frederix GWJ, Lönnqvist T, Suomalainen A, Isohanni P. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children. Eur J Paediatr Neurol 2021;36:30-6. [PMID: 34852981 DOI: 10.1016/j.ejpn.2021.11.006] [Reference Citation Analysis]
33 Naulaerts S, Menden MP, Ballester PJ. Concise Polygenic Models for Cancer-Specific Identification of Drug-Sensitive Tumors from Their Multi-Omics Profiles. Biomolecules 2020;10:E963. [PMID: 32604779 DOI: 10.3390/biom10060963] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ahmed Z, Renart EG, Mishra D, Zeeshan S. JWES: a new pipeline for whole genome/exome sequence data processing, management, and gene-variant discovery, annotation, prediction, and genotyping. FEBS Open Bio 2021. [PMID: 34370400 DOI: 10.1002/2211-5463.13261] [Reference Citation Analysis]
35 Sainio MT, Aaltio J, Hyttinen V, Kortelainen M, Ojanen S, Paetau A, Tienari P, Ylikallio E, Auranen M, Tyynismaa H. Effectiveness of clinical exome sequencing in adult patients with difficult-to-diagnose neurological disorders. Acta Neurol Scand 2022;145:63-72. [PMID: 34418069 DOI: 10.1111/ane.13522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Al-Hashem G, Rotimi VO, Albert MJ. Genetic relatedness of serial rectal isolates of Acinetobacter baumannii in an adult intensive care unit of a tertiary hospital in Kuwait. PLoS One 2020;15:e0230976. [PMID: 32240218 DOI: 10.1371/journal.pone.0230976] [Reference Citation Analysis]
37 Weymann D, Laskin J, Jones SJM, Roscoe R, Lim HJ, Renouf DJ, Schrader KA, Sun S, Yip S, Marra MA, Regier DA. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. J Community Genet 2021. [PMID: 34843087 DOI: 10.1007/s12687-021-00557-w] [Reference Citation Analysis]
38 Mustafi D, Hisama FM, Huey J, Chao JR. The current state of genetic testing platforms for inherited retinal diseases. Ophthalmol Retina 2022:S2468-6530(22)00111-7. [PMID: 35307606 DOI: 10.1016/j.oret.2022.03.011] [Reference Citation Analysis]
39 Ma A, Yousoof S, Grigg JR, Flaherty M, Minoche AE, Cowley MJ, Nash BM, Ho G, Gayagay T, Lai T, Farnsworth E, Hackett EL, Fisk K, Wong K, Holman KJ, Jenkins G, Cheng A, Martin F, Karaconji T, Elder JE, Enriquez A, Wilson M, Amor DJ, Stutterd CA, Kamien B, Nelson J, Dinger ME, Bennetts B, Jamieson RV. Revealing hidden genetic diagnoses in the ocular anterior segment disorders. Genet Med 2020;22:1623-32. [PMID: 32499604 DOI: 10.1038/s41436-020-0854-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
40 Schwarze K, Buchanan J, Fermont JM, Dreau H, Tilley MW, Taylor JM, Antoniou P, Knight SJL, Camps C, Pentony MM, Kvikstad EM, Harris S, Popitsch N, Pagnamenta AT, Schuh A, Taylor JC, Wordsworth S. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genet Med 2020;22:85-94. [PMID: 31358947 DOI: 10.1038/s41436-019-0618-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
41 Tegally H, San JE, Giandhari J, de Oliveira T. Unlocking the efficiency of genomics laboratories with robotic liquid-handling. BMC Genomics 2020;21:729. [PMID: 33081689 DOI: 10.1186/s12864-020-07137-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Al Bakir I, Sebepos-Rogers GM, Burton H, Monahan KJ. Mainstreaming of genomic medicine in gastroenterology, present and future: a nationwide survey of UK gastroenterology trainees. BMJ Open 2019;9:e030505. [PMID: 31640999 DOI: 10.1136/bmjopen-2019-030505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
43 Yoon JG, Hahn HM, Choi S, Kim SJ, Aum S, Yu JW, Park EK, Shim KW, Lee MG, Kim YO. Molecular Diagnosis of Craniosynostosis Using Targeted Next-Generation Sequencing. Neurosurgery 2020;87:294-302. [PMID: 31754721 DOI: 10.1093/neuros/nyz470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
44 Rosenquist R, Cuppen E, Buettner R, Caldas C, Dreau H, Elemento O, Frederix G, Grimmond S, Haferlach T, Jobanputra V, Meggendorfer M, Mullighan CG, Wordsworth S, Schuh A. Clinical utility of whole-genome sequencing in precision oncology. Semin Cancer Biol 2021:S1044-579X(21)00189-9. [PMID: 34175442 DOI: 10.1016/j.semcancer.2021.06.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
45 Peng Z, Zhao Z, Clevenger JP, Chu Y, Paudel D, Ozias-Akins P, Wang J. Comparison of SNP Calling Pipelines and NGS Platforms to Predict the Genomic Regions Harboring Candidate Genes for Nodulation in Cultivated Peanut. Front Genet 2020;11:222. [PMID: 32265983 DOI: 10.3389/fgene.2020.00222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wang HY, Lien F, Liu TP, Chen CH, Chen CJ, Lu JJ. Application of a MALDI-TOF analysis platform (ClinProTools) for rapid and preliminary report of MRSA sequence types in Taiwan. PeerJ 2018;6:e5784. [PMID: 30425884 DOI: 10.7717/peerj.5784] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
47 Liu Z, Zhu L, Roberts R, Tong W. Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We? Trends Genet 2019;35:852-67. [PMID: 31623871 DOI: 10.1016/j.tig.2019.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
48 Belcher A, Mangelsdorf M, McDonald F, Curtis C, Waddell N, Hussey K. What does Australia's investment in genomics mean for public health? Aust N Z J Public Health 2019;43:204-6. [PMID: 30830712 DOI: 10.1111/1753-6405.12887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Nurchis MC, Riccardi MT, Radio FC, Chillemi G, Bertini ES, Tartaglia M, Cicchetti A, Dallapiccola B, Damiani G. Incremental net benefit of Whole Genome Sequencing for newborns and children with suspected genetic disorders: systematic review and meta-analysis of cost-effectiveness evidence. Health Policy 2022. [DOI: 10.1016/j.healthpol.2022.03.001] [Reference Citation Analysis]
50 Wong CN, Fessas P, Dominy K, Mauri FA, Kaneko T, Parcq PD, Khorashad J, Toniutto P, Goldin RD, Avellini C, Pinato DJ. Qualification of tumour mutational burden by targeted next-generation sequencing as a biomarker in hepatocellular carcinoma. Liver Int. 2021;41:192-203. [PMID: 33098208 DOI: 10.1111/liv.14706] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Suwinski P, Ong C, Ling MHT, Poh YM, Khan AM, Ong HS. Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics. Front Genet 2019;10:49. [PMID: 30809243 DOI: 10.3389/fgene.2019.00049] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 19.0] [Reference Citation Analysis]
52 Farmer JR, Mahajan VS. Molecular Diagnosis of Inherited Immune Disorders. Clin Lab Med 2019;39:685-97. [PMID: 31668278 DOI: 10.1016/j.cll.2019.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
53 Uhlig HH, Charbit-Henrion F, Kotlarz D, Shouval DS, Schwerd T, Strisciuglio C, de Ridder L, van Limbergen J, Macchi M, Snapper SB, Ruemmele FM, Wilson DC, Travis SPL, Griffiths AM, Turner D, Klein C, Muise AM, Russell RK; Paediatric IBD Porto group of ESPGHAN. Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2021;72:456-73. [PMID: 33346580 DOI: 10.1097/MPG.0000000000003017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
54 Grosse SD, Gudgeon JM. Cost or price of sequencing? Implications for economic evaluations in genomic medicine. Genet Med 2021;23:1833-5. [PMID: 34113006 DOI: 10.1038/s41436-021-01223-9] [Reference Citation Analysis]
55 Masri A, Hamamy H. Cost Effectiveness of Whole Exome Sequencing for Children with Developmental Delay in a Developing Country: A Study from Jordan. Journal of Pediatric Neurology 2022;20:020-3. [DOI: 10.1055/s-0040-1722265] [Reference Citation Analysis]
56 Koebley SR, Mikheikin A, Leslie K, Guest D, McConnell-Wells W, Lehman JH, Al Juhaishi T, Zhang X, Roberts CH, Picco L, Toor A, Chesney A, Reed J. Digital Polymerase Chain Reaction Paired with High-Speed Atomic Force Microscopy for Quantitation and Length Analysis of DNA Length Polymorphisms. ACS Nano 2020;14:15385-93. [PMID: 33169971 DOI: 10.1021/acsnano.0c05897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
57 Cho JH, Charnot-Katsikas A, Segal J, Pytel P. Identification of Molecular Alterations Challenging Initial Pathologic Classification in Cases of Clinician-Initiated Next-Generation Sequencing Testing. Am J Clin Pathol 2021;156:1007-18. [PMID: 34180985 DOI: 10.1093/ajcp/aqab062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Varesio C, Gana S, Asaro A, Ballante E, Cabini RF, Tartara E, Bagnaschi M, Pasca L, Valente M, Orcesi S, Cereda C, Veggiotti P, Borgatti R, Valente EM, De Giorgis V. Diagnostic Yield and Cost-Effectiveness of "Dynamic" Exome Analysis in Epilepsy with Neurodevelopmental Disorders: A Tertiary-Center Experience in Northern Italy. Diagnostics (Basel) 2021;11:948. [PMID: 34070668 DOI: 10.3390/diagnostics11060948] [Reference Citation Analysis]
59 Alam K, Schofield D. Economic evaluation of genomic sequencing in the paediatric population: a critical review. Eur J Hum Genet 2018;26:1241-7. [PMID: 29795475 DOI: 10.1038/s41431-018-0175-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Vanden Berghe T, Hoste E. Paving the way for precision medicine v2.0 in intensive care by profiling necroinflammation in biofluids. Cell Death Differ 2019;26:83-98. [PMID: 30201975 DOI: 10.1038/s41418-018-0196-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
61 Dragojlovic N, van Karnebeek CDM, Ghani A, Genereaux D, Kim E, Birch P, Elliott AM, Friedman JM, Lynd LD; CAUSES Study. The cost trajectory of the diagnostic care pathway for children with suspected genetic disorders. Genet Med 2020;22:292-300. [DOI: 10.1038/s41436-019-0635-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
62 Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI. Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies. J Neonatal Perinatal Med 2019. [PMID: 31081795 DOI: 10.3233/NPM-181854] [Reference Citation Analysis]
63 Sun H, Shen XR, Fang ZB, Jiang ZZ, Wei XJ, Wang ZY, Yu XF. Next-Generation Sequencing Technologies and Neurogenetic Diseases. Life (Basel) 2021;11:361. [PMID: 33921670 DOI: 10.3390/life11040361] [Reference Citation Analysis]
64 Madaha EL, Mienie C, Gonsu HK, Bughe RN, Fonkoua MC, Mbacham WF, Alayande KA, Bezuidenhout CC, Ateba CN. Whole-genome sequence of multi-drug resistant Pseudomonas aeruginosa strains UY1PSABAL and UY1PSABAL2 isolated from human broncho-alveolar lavage, Yaoundé, Cameroon. PLoS One 2020;15:e0238390. [PMID: 32886694 DOI: 10.1371/journal.pone.0238390] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
65 Hays T, Groopman EE, Gharavi AG. Genetic testing for kidney disease of unknown etiology. Kidney Int 2020;98:590-600. [PMID: 32739203 DOI: 10.1016/j.kint.2020.03.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
66 Song F, Owczarek-Lipska M, Ahmels T, Book M, Aisenbrey S, Menghini M, Barthelmes D, Schrader S, Spital G, Neidhardt J. High-Throughput Sequencing to Identify Mutations Associated with Retinal Dystrophies. Genes (Basel) 2021;12:1269. [PMID: 34440443 DOI: 10.3390/genes12081269] [Reference Citation Analysis]
67 Hayeems RZ, Marshall CR, Gillespie MK, Szuto A, Chisholm C, Stavropoulos DJ, Venkataramanan V, Tsiplova K, Sawyer S, Price EM, Lau L, Khan R, Lee W, Huang L, Jarinova O, Ungar WJ, Mendoza-Londono R, Somerville MJ, Boycott KM. Comparing genome sequencing technologies to improve rare disease diagnostics: a protocol for the evaluation of a pilot project, Genome-wide Sequencing Ontario. CMAJ Open 2022;10:E460-5. [PMID: 35609929 DOI: 10.9778/cmajo.20210272] [Reference Citation Analysis]
68 Lye JJ, Williams A, Baralle D. Exploring the RNA Gap for Improving Diagnostic Yield in Primary Immunodeficiencies. Front Genet 2019;10:1204. [PMID: 31921280 DOI: 10.3389/fgene.2019.01204] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Sobottka B, Weber A. [Molecular tumor diagnostics-current methods, examples of application and future]. Pathologe 2020;41:411-24. [PMID: 32430586 DOI: 10.1007/s00292-020-00793-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Wahl A, Huptas C, Neuhaus K. Comparison of rRNA depletion methods for efficient bacterial mRNA sequencing. Sci Rep 2022;12:5765. [PMID: 35388078 DOI: 10.1038/s41598-022-09710-y] [Reference Citation Analysis]
71 Vazquez M, Valencia A. Patient Dossier: Healthcare queries over distributed resources. PLoS Comput Biol 2019;15:e1007291. [PMID: 31622330 DOI: 10.1371/journal.pcbi.1007291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Michalowitz A, Yang J, Castaneda P, Litrenta J. Existing and emerging methods of diagnosis and monitoring of pediatric musculoskeletal infection. Injury 2020;51:2110-7. [PMID: 32732117 DOI: 10.1016/j.injury.2020.06.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Gaille M, Horn R; UK-FR GENE (Genetics and Ethics Network) Consortia. The ethics of genomic medicine: redefining values and norms in the UK and France. Eur J Hum Genet 2021;29:780-8. [PMID: 33456054 DOI: 10.1038/s41431-020-00798-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisama FM; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021. [PMID: 34211152 DOI: 10.1038/s41436-021-01242-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Wu Y, Al-Janabi H, Mallett A, Quinlan C, Scheffer IE, Howell KB, Christodoulou J, Leventer RJ, Lockhart PJ, Stark Z, Boughtwood T, Goranitis I. Parental health spillover effects of paediatric rare genetic conditions. Qual Life Res 2020;29:2445-54. [PMID: 32266555 DOI: 10.1007/s11136-020-02497-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
76 Lee IH, Negron JA, Hernandez-Ferrer C, Alvarez WJ, Mandl KD, Kong SW. The Clinical Genome and Ancestry Report: An interactive web application for prioritizing clinically implicated variants from genome sequencing data with ancestry composition. Hum Mutat 2020;41:387-96. [PMID: 31691385 DOI: 10.1002/humu.23942] [Reference Citation Analysis]
77 Guo W, Nie Y, Yan Z, Zhu X, Wang Y, Guan S, Kuo Y, Zhang W, Zhi X, Wei Y, Yan L, Qiao J. Genetic testing and PGD for unexplained recurrent fetal malformations with MAGEL2 gene mutation. Sci China Life Sci 2019;62:886-94. [PMID: 31152388 DOI: 10.1007/s11427-019-9541-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Vail E, Song J, Xu J, Frye JS, Kim JT, Pao A, Schreck R, Aguiluz AS, Zhang W, Alkan S, Mita A, Mita M, Figlin RA, Engman DM, Lopategui JR. Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer. Target Oncol 2020;15:523-30. [PMID: 32770442 DOI: 10.1007/s11523-020-00743-9] [Reference Citation Analysis]
79 Russell LE, Zhou Y, Almousa AA, Sodhi JK, Nwabufo CK, Lauschke VM. Pharmacogenomics in the era of next generation sequencing - from byte to bedside. Drug Metab Rev 2021;53:253-78. [PMID: 33820459 DOI: 10.1080/03602532.2021.1909613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
80 Binquet C, Lejeune C, Faivre L, Bouctot M, Asensio ML, Simon A, Deleuze JF, Boland A, Guillemin F, Seror V, Delmas C, Espérou H, Duffourd Y, Lyonnet S, Odent S, Heron D, Sanlaville D, Frebourg T, Gerard B, Dollfus H. Genome Sequencing for Genetics Diagnosis of Patients With Intellectual Disability: The DEFIDIAG Study. Front Genet 2021;12:766964. [PMID: 35178068 DOI: 10.3389/fgene.2021.766964] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Kosaki R, Kubota M, Uehara T, Suzuki H, Takenouchi T, Kosaki K. Consecutive medical exome analysis at a tertiary center: Diagnostic and health-economic outcomes. Am J Med Genet A 2020;182:1601-7. [PMID: 32369273 DOI: 10.1002/ajmg.a.61589] [Reference Citation Analysis]
82 Chen J. A fully-automated event-based variant prioritizing solution to the CAGI5 intellectual disability gene panel challenge. Hum Mutat 2019;40:1364-72. [PMID: 31066479 DOI: 10.1002/humu.23781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
83 Pipis M, Rossor AM, Laura M, Reilly MM. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges. Nat Rev Neurol 2019;15:644-56. [PMID: 31582811 DOI: 10.1038/s41582-019-0254-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
84 Martín-Sánchez M, Bravo-Gil N, González-Del Pozo M, Méndez-Vidal C, Fernández-Suárez E, Rodríguez-de la Rúa E, Borrego S, Antiñolo G. A Multi-Strategy Sequencing Workflow in Inherited Retinal Dystrophies: Routine Diagnosis, Addressing Unsolved Cases and Candidate Genes Identification. Int J Mol Sci 2020;21:E9355. [PMID: 33302505 DOI: 10.3390/ijms21249355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Shickh S, Mighton C, Uleryk E, Pechlivanoglou P, Bombard Y. The clinical utility of exome and genome sequencing across clinical indications: a systematic review. Hum Genet 2021. [PMID: 34368901 DOI: 10.1007/s00439-021-02331-x] [Reference Citation Analysis]
86 Sukasem C, Jantararoungtong T, Koomdee N. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings. Drug Metab Pharmacokinet 2021;39:100399. [PMID: 34098253 DOI: 10.1016/j.dmpk.2021.100399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Lejeune C, Amado IF; DEFIDIAG study group, FHU Translad and Aviesan. Valuing genetic and genomic testing in France: current challenges and latest evidence. J Community Genet 2021. [PMID: 33453057 DOI: 10.1007/s12687-020-00503-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
88 Wang X, Wang Y, Hong D, Zhang Z, Li Y, Yang P, Sun Y, Jiang T, Xu Z. Combined genetic screening and traditional biochemical screening to optimize newborn screening systems. Clinica Chimica Acta 2022. [DOI: 10.1016/j.cca.2022.01.015] [Reference Citation Analysis]
89 Arbitrio M, Scionti F, Di Martino MT, Caracciolo D, Pensabene L, Tassone P, Tagliaferri P. Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice. Clin Transl Sci 2021;14:113-9. [PMID: 33089968 DOI: 10.1111/cts.12869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Yang X, Li Z, Wang Q, Zhang Y, Zhao C. Novel pathogenic variant of MYBPC3 responsible for hypertrophic cardiomyopathy. Cardiol Young 2021;:1-6. [PMID: 34180388 DOI: 10.1017/S1047951121002468] [Reference Citation Analysis]
91 Wang H, Lu Y, Dong X, Lu G, Cheng G, Qian Y, Ni Q, Zhang P, Yang L, Wu B, Zhou W. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China. Hum Genet 2020;139:473-82. [DOI: 10.1007/s00439-019-02103-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
92 Wu Y, Balasubramaniam S, Rius R, Thorburn DR, Christodoulou J, Goranitis I. Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation. Eur J Hum Genet 2021. [PMID: 34099885 DOI: 10.1038/s41431-021-00916-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
93 Addeo A, Friedlaender A, Banna GL, Weiss GJ. TMB or not TMB as a biomarker: That is the question. Crit Rev Oncol Hematol 2021;163:103374. [PMID: 34087341 DOI: 10.1016/j.critrevonc.2021.103374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Agampodi SB, Vinetz JM. Next-Generation Sequencing Analysis of Pathogenic Leptospira: A Way Forward for Understanding Infectious Disease Dynamics in Low/Middle-Income, Disease-Endemic Settings. Am J Trop Med Hyg 2021:tpmd201518. [PMID: 33755589 DOI: 10.4269/ajtmh.20-1518] [Reference Citation Analysis]
95 Khan M, Cornelis SS, Khan MI, Elmelik D, Manders E, Bakker S, Derks R, Neveling K, van de Vorst M, Gilissen C, Meunier I, Defoort S, Puech B, Devos A, Schulz HL, Stöhr H, Grassmann F, Weber BHF, Dhaenens CM, Cremers FPM. Cost-effective molecular inversion probe-based ABCA4 sequencing reveals deep-intronic variants in Stargardt disease. Hum Mutat 2019;40:1749-59. [PMID: 31212395 DOI: 10.1002/humu.23787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
96 Frueh JS, Press DZ, Sanders JS. Diagnosis and Workup of Intellectual Disability in Adults: Suggested Strategies for the Adult Neurologist. Neurol Clin Pract 2021;11:534-40. [PMID: 34992961 DOI: 10.1212/CPJ.0000000000001128] [Reference Citation Analysis]
97 Banerjee S, Kumar A, Lopez N, Zhao B, Tang CM, Yebra M, Yoon H, Murphy JD, Sicklick JK. Cost-effectiveness Analysis of Genetic Testing and Tailored First-Line Therapy for Patients With Metastatic Gastrointestinal Stromal Tumors. JAMA Netw Open 2020;3:e2013565. [PMID: 32986105 DOI: 10.1001/jamanetworkopen.2020.13565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Mazzarotto F, Olivotto I, Boschi B, Girolami F, Poggesi C, Barton PJR, Walsh R. Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? J Am Heart Assoc 2020;9:e015473. [PMID: 32306808 DOI: 10.1161/JAHA.119.015473] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
99 Lane WJ, Vege S, Mah HH, Lomas-Francis C, Aguad M, Smeland-Wagman R, Koch C, Killian JM, Gardner CL, De Castro M, Lebo MS, Kaufman RM, Green RC, Westhoff CM; MilSeq Project. Automated typing of red blood cell and platelet antigens from whole exome sequences. Transfusion 2019;59:3253-63. [PMID: 31392742 DOI: 10.1111/trf.15473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
100 Zhao X, Bian C, Liu K, Xu W, Liu Y, Tian X, Bai J, Xu KF, Zhang X. Clinical characteristics and genetic spectrum of 26 individuals of Chinese origin with primary ciliary dyskinesia. Orphanet J Rare Dis 2021;16:293. [PMID: 34210339 DOI: 10.1186/s13023-021-01840-2] [Reference Citation Analysis]
101 Alsubaie L, Aloraini T, Amoudi M, Swaid A, Eyiad W, Al Mutairi F, Ababneh F, Alrifai MT, Baarmah D, Altwaijri W, Alotaibi N, Harthi A, Rumayyan A, Alanazi A, Qrimli M, Alfadhel M, Alfares A. Genomic testing and counseling: The contribution of next-generation sequencing to epilepsy genetics. Ann Hum Genet 2020;84:431-6. [PMID: 32533790 DOI: 10.1111/ahg.12397] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Kotsanopoulos KV, Exadactylos A, Gkafas GA, Martsikalis PV, Parlapani FF, Boziaris IS, Arvanitoyannis IS. The use of molecular markers in the verification of fish and seafood authenticity and the detection of adulteration. Compr Rev Food Sci Food Saf 2021;20:1584-654. [PMID: 33586855 DOI: 10.1111/1541-4337.12719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Forny P, Footitt E, Davison JE, Lam A, Woodward CE, Batzios S, Bhate S, Chakrapani A, Cleary M, Gissen P, Grunewald S, Hurst JA, Scott R, Heales S, Jacques TS, Cullup T, Rahman S. Diagnosing Mitochondrial Disorders Remains Challenging in the Omics Era. Neurol Genet 2021;7:e597. [PMID: 34056100 DOI: 10.1212/NXG.0000000000000597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Chaudhari BP, Manickam K, McBride KL. A pediatric perspective on genomics and prevention in the twenty-first century. Pediatr Res 2020;87:338-44. [PMID: 31578042 DOI: 10.1038/s41390-019-0597-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
105 Friedman JM, Bombard Y, Cornel MC, Fernandez CV, Junker AK, Plon SE, Stark Z, Knoppers BM; Paediatric Task Team of the Global Alliance for Genomics and Health Regulatory and Ethics Work Stream. Genome-wide sequencing in acutely ill infants: genomic medicine's critical application? Genet Med 2019;21:498-504. [PMID: 29895853 DOI: 10.1038/s41436-018-0055-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
106 Zhong Y, Xu F, Wu J, Schubert J, Li MM. Application of Next Generation Sequencing in Laboratory Medicine. Ann Lab Med 2021;41:25-43. [PMID: 32829577 DOI: 10.3343/alm.2021.41.1.25] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
107 Shickh S, Gutierrez Salazar M, Zakoor KR, Lázaro C, Gu J, Goltz J, Kleinman D, Noor A, Khalouei S, Mighton C, Reble E, Kodida R, Bombard Y, DiTroia S, Baxter S, Watkins N, Care M, Adler A, Horsburgh S, Morar O, Murphy J, Nevay DL, Szybowska M, Aronson M, Panchal S, Godoy R, Holter S, Randall Armel S, Semotiuk K, Elser C, Kim RH, Chitayat D, So J, Faghfoury H, Silver J, Morel CF, Lerner-Ellis J. Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study. J Med Genet 2021;58:275-83. [PMID: 32581083 DOI: 10.1136/jmedgenet-2020-106936] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
108 Zhou X, Qu M, Tebon P, Jiang X, Wang C, Xue Y, Zhu J, Zhang S, Oklu R, Sengupta S, Sun W, Khademhosseini A. Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial Intelligence. Adv Sci (Weinh) 2020;7:2001447. [PMID: 33042756 DOI: 10.1002/advs.202001447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
109 Conboy C. Consent and Privacy in the Era of Precision Medicine and Biobanking Genomic Data. Am J Law Med 2020;46:167-87. [PMID: 32659188 DOI: 10.1177/0098858820933493] [Reference Citation Analysis]
110 Fahr P, Buchanan J, Wordsworth S. A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders. Pharmacoeconomics 2020;38:143-58. [PMID: 31741314 DOI: 10.1007/s40273-019-00856-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Hübel C, Leppä V, Breen G, Bulik CM. Rigor and reproducibility in genetic research on eating disorders. Int J Eat Disord 2018;51:593-607. [DOI: 10.1002/eat.22896] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
112 Koomdee N, Kloypan C, Jinda P, Rachanakul J, Jantararoungtong T, Sukprasong R, Prommas S, Nuntharadthanaphong N, Puangpetch A, Ershadian M, John S, Biswas M, Sukasem C. Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand. Front Pharmacol 2022;13:866903. [PMID: 35450046 DOI: 10.3389/fphar.2022.866903] [Reference Citation Analysis]
113 Plumpton CO, Pirmohamed M, Hughes DA. Cost‐Effectiveness of Panel Tests for Multiple Pharmacogenes Associated With Adverse Drug Reactions: An Evaluation Framework. Clin Pharmacol Ther 2019;105:1429-38. [DOI: 10.1002/cpt.1312] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
114 Kapoor B, Kumar A, Kumar P. Transcriptome repository of North-Western Himalayan endangered medicinal herbs: a paramount approach illuminating molecular perspective of phytoactive molecules and secondary metabolism. Mol Genet Genomics 2021;296:1177-202. [PMID: 34557965 DOI: 10.1007/s00438-021-01821-x] [Reference Citation Analysis]
115 Lalonde E, Rentas S, Lin F, Dulik MC, Skraban CM, Spinner NB. Genomic Diagnosis for Pediatric Disorders: Revolution and Evolution. Front Pediatr 2020;8:373. [PMID: 32733828 DOI: 10.3389/fped.2020.00373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
116 Howell KB, Eggers S, Dalziel K, Riseley J, Mandelstam S, Myers CT, McMahon JM, Schneider A, Carvill GL, Mefford HC, Scheffer IE, Harvey AS; Victorian Severe Epilepsy of Infancy Study Group. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy. Epilepsia 2018;59:1177-87. [PMID: 29750358 DOI: 10.1111/epi.14087] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
117 Mozheiko EA, Fishman VS. Detection of Point Mutations and Chromosomal Translocations Based on Massive Parallel Sequencing of Enriched 3C Libraries. Russ J Genet 2019;55:1273-81. [DOI: 10.1134/s1022795419100089] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
118 Chen Y, Chirikov VV, Marston XL, Yang J, Qiu H, Xie J, Sun N, Gu C, Dong P, Gao X. Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps. J Health Econ Outcomes Res 2020;7:35-42. [PMID: 32685596 DOI: 10.36469/jheor.2020.12698] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
119 Zhou Y, Krebs K, Milani L, Lauschke VM. Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing. Clin Pharmacol Ther 2021;109:160-74. [PMID: 32535895 DOI: 10.1002/cpt.1944] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
120 Vincent J, Sakr Y. Clinical trial design for unmet clinical needs: a spotlight on sepsis. Expert Review of Clinical Pharmacology 2019;12:893-900. [DOI: 10.1080/17512433.2019.1643235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
121 Jain P, Andrade D, Donner E, Dyment D, Prasad AN, Goobie S, Boycott K, Lines M, Snead OC. Development of Criteria for Epilepsy Genetic Testing in Ontario, Canada. Can J Neurol Sci 2019;46:7-13. [DOI: 10.1017/cjn.2018.341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
122 Vrijenhoek T, Middelburg EM, Monroe GR, van Gassen KLI, Geenen JW, Hövels AM, Knoers NV, van Amstel HKP, Frederix GWJ. Whole-exome sequencing in intellectual disability; cost before and after a diagnosis. Eur J Hum Genet 2018;26:1566-71. [PMID: 29959382 DOI: 10.1038/s41431-018-0203-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
123 Fung JLF, Yu MHC, Huang S, Chung CCY, Chan MCY, Pajusalu S, Mak CCY, Hui VCC, Tsang MHY, Yeung KS, Lek M, Chung BHY. A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis. NPJ Genom Med 2020;5:37. [PMID: 32963807 DOI: 10.1038/s41525-020-00144-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
124 Sultova E, Westphalen CB, Jung A, Kumbrink J, Kirchner T, Mayr D, Rudelius M, Ormanns S, Heinemann V, Metzeler KH, Greif PA, Burges A, Trillsch F, Mahner S, Harbeck N, Wuerstlein R. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU. Arch Gynecol Obstet 2021;303:1331-45. [PMID: 33277683 DOI: 10.1007/s00404-020-05881-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
125 Doble B, Schofield D, Evans CA, Groza T, Mattick JS, Field M, Roscioli T. Impacts of genomics on the health and social costs of intellectual disability. J Med Genet 2020;57:479-86. [PMID: 31980565 DOI: 10.1136/jmedgenet-2019-106445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
126 Gyngell C, Newson AJ, Wilkinson D, Stark Z, Savulescu J. Rapid Challenges: Ethics and Genomic Neonatal Intensive Care. Pediatrics 2019;143:S14-21. [PMID: 30600266 DOI: 10.1542/peds.2018-1099D] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
127 Walpole S, Hayward NK, Pritchard AL, Johansson PA. Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in BAP1 Pathogenic Variant Carriers. JCO Clin Cancer Inform 2021;5:143-54. [PMID: 33513031 DOI: 10.1200/CCI.20.00124] [Reference Citation Analysis]
128 Wang Q, Peng WX, Wang L, Ye L. Toward multiomics-based next-generation diagnostics for precision medicine. Per Med 2019;16:157-70. [PMID: 30816060 DOI: 10.2217/pme-2018-0085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
129 Miao H, Zhou J, Yang Q, Liang F, Wang D, Ma N, Gao B, Du J, Lin G, Wang K, Zhang Q. Long-read sequencing identified a causal structural variant in an exome-negative case and enabled preimplantation genetic diagnosis. Hereditas 2018;155:32. [PMID: 30279644 DOI: 10.1186/s41065-018-0069-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
130 Simons MJHG, Retèl VP, Ramaekers BLT, Butter R, Mankor JM, Paats MS, Aerts JGJV, Mfumbilwa ZA, Roepman P, Coupé VMH, Uyl-de Groot CA, van Harten WH, Joore MA. Early Cost Effectiveness of Whole-Genome Sequencing as a Clinical Diagnostic Test for Patients with Inoperable Stage IIIB,C/IV Non-squamous Non-small-Cell Lung Cancer. Pharmacoeconomics 2021. [PMID: 34405371 DOI: 10.1007/s40273-021-01073-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Wang C, Baer HM, Gaya DR, Nibbs RJB, Milling S. Can molecular stratification improve the treatment of inflammatory bowel disease? Pharmacol Res 2019;148:104442. [PMID: 31491469 DOI: 10.1016/j.phrs.2019.104442] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
132 Abbott M, McKenzie L, Moran BVG, Heidenreich S, Hernández R, Hocking-Mennie L, Clark C, Gomes J, Lampe A, Baty D, McGowan R, Miedzybrodzka Z, Ryan M. Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland. J Community Genet 2021. [PMID: 34415556 DOI: 10.1007/s12687-021-00541-4] [Reference Citation Analysis]
133 Christofyllakis K, Bittenbring JT, Thurner L, Ahlgrimm M, Stilgenbauer S, Bewarder M, Kaddu-Mulindwa D. Cost-effectiveness of precision cancer medicine-current challenges in the use of next generation sequencing for comprehensive tumour genomic profiling and the role of clinical utility frameworks (Review). Mol Clin Oncol 2022;16:21. [PMID: 34909199 DOI: 10.3892/mco.2021.2453] [Reference Citation Analysis]
134 Hiraide T, Shimizu K, Miyamoto S, Aoto K, Nakashima M, Yamaguchi T, Kosho T, Ogata T, Saitsu H. Genome sequencing and RNA sequencing of urinary cells reveal an intronic FBN1 variant causing aberrant splicing. J Hum Genet. [DOI: 10.1038/s10038-022-01016-1] [Reference Citation Analysis]
135 Satti FA, Ali T, Hussain J, Khan WA, Khattak AM, Lee S. Ubiquitous Health Profile (UHPr): a big data curation platform for supporting health data interoperability. Computing 2020;102:2409-44. [DOI: 10.1007/s00607-020-00837-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
136 Pruneri G, De Braud F, Sapino A, Aglietta M, Vecchione A, Giusti R, Marchiò C, Scarpino S, Baggi A, Bonetti G, Franzini JM, Volpe M, Jommi C. Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? Pharmacoecon Open 2021;5:285-98. [PMID: 33660227 DOI: 10.1007/s41669-020-00249-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
137 Shaikh MH, Barrett JW, Khan MI, Kim HAJ, Zeng PYF, Mymryk JS, Nichols AC. Chromosome 3p loss in the progression and prognosis of head and neck cancer. Oral Oncol 2020;109:104944. [PMID: 32828022 DOI: 10.1016/j.oraloncology.2020.104944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
138 Ostrander BEP, Butterfield RJ, Pedersen BS, Farrell AJ, Layer RM, Ward A, Miller C, DiSera T, Filloux FM, Candee MS, Newcomb T, Bonkowsky JL, Marth GT, Quinlan AR. Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy. NPJ Genom Med 2018;3:22. [PMID: 30109124 DOI: 10.1038/s41525-018-0061-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
139 Jegathisawaran J, Tsiplova K, Hayeems R, Ungar WJ. Determining accurate costs for genomic sequencing technologies-a necessary prerequisite. J Community Genet 2020;11:235-8. [PMID: 31728779 DOI: 10.1007/s12687-019-00442-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
140 Duy PQ, Timberlake AT, Lifton RP, Kahle KT. Molecular genetics of human developmental neurocranial anomalies: towards "precision surgery". Cereb Cortex 2022:bhac249. [PMID: 35739418 DOI: 10.1093/cercor/bhac249] [Reference Citation Analysis]
141 Homma TK, Freire BL, Honjo Kawahira RS, Dauber A, Funari MFA, Lerario AM, Nishi MY, Albuquerque EV, Vasques GA, Collett-Solberg PF, Miura Sugayama SM, Bertola DR, Kim CA, Arnhold IJP, Malaquias AC, Jorge AAL. Genetic Disorders in Prenatal Onset Syndromic Short Stature Identified by Exome Sequencing. J Pediatr 2019;215:192-8. [PMID: 31630891 DOI: 10.1016/j.jpeds.2019.08.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
142 Buchanan J, Wordsworth S. Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research. Pharmacoecon Open 2019;3:129-32. [PMID: 30284701 DOI: 10.1007/s41669-018-0101-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
143 Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L; MC3 Working Group., PCAWG novel somatic mutation calling methods working group., PCAWG Consortium. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun 2020;11:4748. [PMID: 32958763 DOI: 10.1038/s41467-020-18151-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
144 Hoffman JA, Arora R. Arrhythmogenic cardiomyopathy: in search of unifying genetic theory. Cardiovasc Res 2019;115:691-2. [PMID: 30649223 DOI: 10.1093/cvr/cvy315] [Reference Citation Analysis]
145 Anderson D, Baynam G, Blackwell JM, Lassmann T. Personalised analytics for rare disease diagnostics. Nat Commun 2019;10:5274. [PMID: 31754101 DOI: 10.1038/s41467-019-13345-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
146 Downie L, Amor DJ, Halliday J, Lewis S, Martyn M, Goranitis I. Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis. Laryngoscope 2021;131:E2371-7. [PMID: 33382469 DOI: 10.1002/lary.29356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Kim Y, Shiba-Ishii A, Ramirez K, Muratani M, Sakamoto N, Iijima T, Noguchi M. Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma. Cancer Sci 2019;110:2431-41. [PMID: 31144406 DOI: 10.1111/cas.14081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
148 Cloney T, Gallacher L, Pais LS, Tan NB, Yeung A, Stark Z, Brown NJ, McGillivray G, Delatycki MB, de Silva MG, Downie L, Stutterd CA, Elliott J, Compton AG, Lovgren A, Oertel R, Francis D, Bell KM, Sadedin S, Lim SC, Helman G, Simons C, Macarthur DG, Thorburn DR, O'Donnell-Luria AH, Christodoulou J, White SM, Tan TY. Lessons learnt from multifaceted diagnostic approaches to the first 150 families in Victoria's Undiagnosed Diseases Program. J Med Genet 2021:jmedgenet-2021-107902. [PMID: 34740920 DOI: 10.1136/jmedgenet-2021-107902] [Reference Citation Analysis]
149 Laviolle B, Denèfle P, Gueyffier F, Bégué É, Bilbault P, Espérou H, Gaillard-bigot F, Grenet G, Guérin J, Guillot C, Longeray P, Morere J, Perche O, Perrier L, Sanlaville D, Thevenon J, Varoqueaux N. The contribution of genomics in the medicine of tomorrow, clinical applications and issues. Therapies 2019;74:9-15. [DOI: 10.1016/j.therap.2018.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
150 Rampersad SN. Pathogenomics and Management of Fusarium Diseases in Plants. Pathogens 2020;9:E340. [PMID: 32369942 DOI: 10.3390/pathogens9050340] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
151 Chiu FP, Doolan BJ, McGrath JA, Onoufriadis A. A decade of next-generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics. Br J Dermatol 2021;184:606-16. [PMID: 32628274 DOI: 10.1111/bjd.19384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
152 Pearce C, Goettke E, Hallowell N, McCormack P, Flinter F, McKevitt C. Delivering genomic medicine in the United Kingdom National Health Service: a systematic review and narrative synthesis. Genet Med 2019;21:2667-75. [PMID: 31186523 DOI: 10.1038/s41436-019-0579-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
153 Hiraide T, Nakashima M, Ikeda T, Tanaka D, Osaka H, Saitsu H. Identification of a deep intronic POLR3A variant causing inclusion of a pseudoexon derived from an Alu element in Pol III-related leukodystrophy. J Hum Genet 2020;65:921-5. [PMID: 32483275 DOI: 10.1038/s10038-020-0786-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
154 Méjécase C, Malka S, Guan Z, Slater A, Arno G, Moosajee M. Practical guide to genetic screening for inherited eye diseases. Ther Adv Ophthalmol 2020;12:2515841420954592. [PMID: 33015543 DOI: 10.1177/2515841420954592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
155 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
156 Navarrete R, Leal F, Vega AI, Morais-López A, Garcia-Silva MT, Martín-Hernández E, Quijada-Fraile P, Bergua A, Vives I, García-Jiménez I, Yahyaoui R, Pedrón-Giner C, Belanger-Quintana A, Stanescu S, Cañedo E, García-Campos O, Bueno-Delgado M, Delgado-Pecellín C, Vitoria I, Rausell MD, Balmaseda E, Couce ML, Desviat LR, Merinero B, Rodríguez-Pombo P, Ugarte M, Pérez-Cerdá C, Pérez B. Value of genetic analysis for confirming inborn errors of metabolism detected through the Spanish neonatal screening program. Eur J Hum Genet 2019;27:556-62. [PMID: 30626930 DOI: 10.1038/s41431-018-0330-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
157 Pal LR, Kundu K, Yin Y, Moult J. Matching whole genomes to rare genetic disorders: Identification of potential causative variants using phenotype-weighted knowledge in the CAGI SickKids5 clinical genomes challenge. Hum Mutat 2020;41:347-62. [PMID: 31680375 DOI: 10.1002/humu.23933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
158 Bauer A, Zierer A, Gieger C, Büyüközkan M, Müller-Nurasyid M, Grallert H, Meisinger C, Strauch K, Prokisch H, Roden M, Peters A, Krumsiek J, Herder C, Koenig W, Thorand B, Huth C. Comparison of genetic risk prediction models to improve prediction of coronary heart disease in two large cohorts of the MONICA/KORA study. Genet Epidemiol 2021;45:633-50. [PMID: 34082474 DOI: 10.1002/gepi.22389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Narayanan DL, Girisha KM. Genomic Testing for Diagnosis of Genetic Disorders in Children: Chromosomal Microarray and Next—Generation Sequencing. Indian Pediatr 2020;57:549-54. [DOI: 10.1007/s13312-020-1853-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
160 Smith HS, Swint JM, Lalani SR, de Oliveira Otto MC, Yamal JM, Russell HV, Lee BH. Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions. Genet Med 2020;22:1303-10. [PMID: 32336750 DOI: 10.1038/s41436-020-0798-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
161 Hehir-Kwa JY, Tops BBJ, Kemmeren P. The clinical implementation of copy number detection in the age of next-generation sequencing. Expert Rev Mol Diagn 2018;18:907-15. [PMID: 30221560 DOI: 10.1080/14737159.2018.1523723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
162 Trudsø LC, Andersen JD, Jacobsen SB, Christiansen SL, Congost-Teixidor C, Kampmann ML, Morling N. A comparative study of single nucleotide variant detection performance using three massively parallel sequencing methods. PLoS One 2020;15:e0239850. [PMID: 32986766 DOI: 10.1371/journal.pone.0239850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
163 Siddiqui MT, Schmitt F, Churg A. Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma. Journal of the American Society of Cytopathology 2019;8:352-61. [DOI: 10.1016/j.jasc.2019.07.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
164 Wang S, Tong Y, Zong H, Xu X, Crabbe MJC, Wang Y, Zhang X. Multi-Level Analysis and Identification of Tumor Mutational Burden Genes across Cancer Types. Genes 2022;13:365. [DOI: 10.3390/genes13020365] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Veenstra DL, Mandelblatt J, Neumann P, Basu A, Peterson JF, Ramsey SD. Health Economics Tools and Precision Medicine: Opportunities and Challenges. Forum for Health Economics and Policy 2020;23. [DOI: 10.1515/fhep-2019-0013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
166 Lanillos J, Carcajona M, Maietta P, Alvarez S, Rodriguez-Antona C. Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data. NPJ Genom Med 2022;7:12. [PMID: 35181665 DOI: 10.1038/s41525-022-00283-3] [Reference Citation Analysis]
167 Vu M, Degeling K, Thompson ER, Blombery P, Westerman D, IJzerman MJ. Health economic evidence for the use of molecular biomarker tests in hematological malignancies: A systematic review. Eur J Haematol 2022;108:469-85. [PMID: 35158410 DOI: 10.1111/ejh.13755] [Reference Citation Analysis]
168 Simons M, Van De Ven M, Coupé V, Joore M, IJzerman M, Koffijberg E, Frederix G, Uyl-De Groot C, Cuppen E, Van Harten W, Retèl V. Early technology assessment of using whole genome sequencing in personalized oncology. Expert Rev Pharmacoecon Outcomes Res 2021;21:343-51. [PMID: 33910430 DOI: 10.1080/14737167.2021.1917386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Akkari YMN, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, Diez Campelo M, Gallego MS, Granada Font I, Haase DT, Schlegelberger B, Slavutsky I, Mecucci C, Levine RL, Hasserjian RP, Solé F, Levy B, Xu X. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood 2022;139:2273-84. [PMID: 35167654 DOI: 10.1182/blood.2021014309] [Reference Citation Analysis]
170 Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, Sapkota B. Advances in diagnosis of Tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep 2020;47:4065-75. [DOI: 10.1007/s11033-020-05413-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
171 van de Ven M, Koffijberg H, Retèl V, Monkhorst K, Smit E, van Harten W, IJzerman M. Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals. J Mol Diagn 2021;23:484-94. [PMID: 33493663 DOI: 10.1016/j.jmoldx.2021.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
172 Ali Khan I. Do second generation sequencing techniques identify documented genetic markers for neonatal diabetes mellitus? Heliyon 2021;7:e07903. [PMID: 34584998 DOI: 10.1016/j.heliyon.2021.e07903] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Kumar S, Yadav N, Pandey S, Muthane UB, Govindappa ST, Abbas MM, Behari M, Thelma BK. Novel and reported variants in Parkinson's disease genes confer high disease burden among Indians. Parkinsonism Relat Disord 2020;78:46-52. [PMID: 32707456 DOI: 10.1016/j.parkreldis.2020.07.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
174 Graham DW, Bergeron G, Bourassa MW, Dickson J, Gomes F, Howe A, Kahn LH, Morley PS, Scott HM, Simjee S, Singer RS, Smith TC, Storrs C, Wittum TE. Complexities in understanding antimicrobial resistance across domesticated animal, human, and environmental systems. Ann N Y Acad Sci 2019;1441:17-30. [PMID: 30924539 DOI: 10.1111/nyas.14036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
175 Gordon LG, White NM, Elliott TM, Nones K, Beckhouse AG, Rodriguez-Acevedo AJ, Webb PM, Lee XJ, Graves N, Schofield DJ. Estimating the costs of genomic sequencing in cancer control. BMC Health Serv Res 2020;20:492. [PMID: 32493298 DOI: 10.1186/s12913-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
176 Kim M, Harmanci AO, Bossuat JP, Carpov S, Cheon JH, Chillotti I, Cho W, Froelicher D, Gama N, Georgieva M, Hong S, Hubaux JP, Kim D, Lauter K, Ma Y, Ohno-Machado L, Sofia H, Son Y, Song Y, Troncoso-Pastoriza J, Jiang X. Ultrafast homomorphic encryption models enable secure outsourcing of genotype imputation. Cell Syst 2021:S2405-4712(21)00288-X. [PMID: 34464590 DOI: 10.1016/j.cels.2021.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
177 Syeda MM, Wiggins JM, Corless B, Spittle C, Karlin-neumann G, Polsky D. Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma. In: Thurin M, Cesano A, Marincola FM, editors. Biomarkers for Immunotherapy of Cancer. New York: Springer; 2020. pp. 155-80. [DOI: 10.1007/978-1-4939-9773-2_7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
178 Yang Y, Zhao S, Sun G, Chen F, Zhang T, Song J, Yang W, Wang L, Zhan N, Yang X, Zhu X, Rao B, Yin Z, Zhou J, Yan H, Huang Y, Ye J, Huang H, Cheng C, Zhu S, Guo J, Xu X, Chen X. Genomic architecture of fetal central nervous system anomalies using whole-genome sequencing. NPJ Genom Med 2022;7:31. [PMID: 35562572 DOI: 10.1038/s41525-022-00301-4] [Reference Citation Analysis]
179 Dockery A, Whelan L, Humphries P, Farrar GJ. Next-Generation Sequencing Applications for Inherited Retinal Diseases. Int J Mol Sci 2021;22:5684. [PMID: 34073611 DOI: 10.3390/ijms22115684] [Reference Citation Analysis]
180 Dong J, Williams N, Cerrone M, Borck C, Wang D, Zhou B, Eng LS, Subbotina E, Um SY, Lin Y, Ruiter K, Rojas L, Coetzee WA, Sampson BA, Tang Y. Molecular autopsy: using the discovery of a novel de novo pathogenic variant in the KCNH2 gene to inform healthcare of surviving family. Heliyon 2018;4:e01015. [PMID: 30582040 DOI: 10.1016/j.heliyon.2018.e01015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
181 Schofield D, Rynehart L, Shresthra R, White SM, Stark Z. Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes. Genet Med 2019;21:2586-93. [DOI: 10.1038/s41436-019-0534-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
182 Gileles-Hillel A, Mor-Shaked H, Shoseyov D, Reiter J, Tsabari R, Hevroni A, Cohen-Cymberknoh M, Amirav I, Brammli-Greenberg S, Horani A, Kerem E, Breuer O. Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia. ERJ Open Res 2020;6:00213-2020. [PMID: 33447612 DOI: 10.1183/23120541.00213-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Wang L, Ren A, Tian T, Li N, Cao X, Zhang P, Jin L, Li Z, Shen Y, Zhang B, Finnell RH, Lei Y. Whole-Exome Sequencing Identifies Damaging de novo Variants in Anencephalic Cases. Front Neurosci 2019;13:1285. [PMID: 31849593 DOI: 10.3389/fnins.2019.01285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
184 Uveges MK, Holm IA. Current Trends in Genetics and Neonatal Care. Adv Neonatal Care 2021;21:473-81. [PMID: 33538495 DOI: 10.1097/ANC.0000000000000834] [Reference Citation Analysis]
185 Jayasinghe K, Stark Z, Patel C, Mallawaarachchi A, McCarthy H, Faull R, Chakera A, Sundaram M, Jose M, Kerr P, Wu Y, Wardrop L, Goranitis I, Best S, Martyn M, Quinlan C, Mallett AJ. Comprehensive evaluation of a prospective Australian patient cohort with suspected genetic kidney disease undergoing clinical genomic testing: a study protocol. BMJ Open 2019;9:e029541. [PMID: 31383705 DOI: 10.1136/bmjopen-2019-029541] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Raymond FL. Clinical Genomics in Critically Ill Infants and Children. JAMA 2020;323:2480-2. [PMID: 32573653 DOI: 10.1001/jama.2020.8112] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Shajii A, Numanagić I, Whelan C, Berger B. Statistical Binning for Barcoded Reads Improves Downstream Analyses. Cell Syst 2018;7:219-226.e5. [PMID: 30138581 DOI: 10.1016/j.cels.2018.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
188 Snoek R, van Jaarsveld RH, Nguyen TQ, Peters EDJ, Elferink MG, Ernst RF, Rookmaaker MB, Lilien MR, Spierings E, Goldschmeding R, Knoers NVAM, van der Zwaag B, van Zuilen AD, van Eerde AM. Genetics-first approach improves diagnostics of ESKD patients younger than 50 years. Nephrol Dial Transplant 2020:gfaa363. [PMID: 33306124 DOI: 10.1093/ndt/gfaa363] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Dagenais S, Russo L, Madsen A, Webster J, Becnel L. Use of Real-World Evidence to Drive Drug Development Strategy and Inform Clinical Trial Design. Clin Pharmacol Ther 2022;111:77-89. [PMID: 34839524 DOI: 10.1002/cpt.2480] [Reference Citation Analysis]
190 Sadikovic B, Levy MA, Kerkhof J, Aref-Eshghi E, Schenkel L, Stuart A, McConkey H, Henneman P, Venema A, Schwartz CE, Stevenson RE, Skinner SA, DuPont BR, Fletcher RS, Balci TB, Siu VM, Granadillo JL, Masters J, Kadour M, Friez MJ, van Haelst MM, Mannens MMAM, Louie RJ, Lee JA, Tedder ML, Alders M. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders. Genet Med 2021;23:1065-74. [PMID: 33547396 DOI: 10.1038/s41436-020-01096-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
191 Shieh JT, Penon-Portmann M, Wong KHY, Levy-Sakin M, Verghese M, Slavotinek A, Gallagher RC, Mendelsohn BA, Tenney J, Beleford D, Perry H, Chow SK, Sharo AG, Brenner SE, Qi Z, Yu J, Klein OD, Martin D, Kwok PY, Boffelli D. Application of full-genome analysis to diagnose rare monogenic disorders. NPJ Genom Med 2021;6:77. [PMID: 34556655 DOI: 10.1038/s41525-021-00241-5] [Reference Citation Analysis]
192 Pinto E Vairo F, Lazaridis KN. Individualized medicine comes to the liver clinic. J Hepatol 2019;70:1057-9. [PMID: 31000362 DOI: 10.1016/j.jhep.2019.03.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
193 Scala M, Bianchi A, Bisulli F, Coppola A, Elia M, Trivisano M, Pruna D, Pippucci T, Canafoglia L, Lattanzi S, Franceschetti S, Nobile C, Gambardella A, Michelucci R, Zara F, Striano P. Advances in genetic testing and optimization of clinical management in children and adults with epilepsy. Expert Rev Neurother 2020;20:251-69. [PMID: 31941393 DOI: 10.1080/14737175.2020.1713101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
194 Beyzaei Z, Geramizadeh B, Karimzadeh S. Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature. Orphanet J Rare Dis 2020;15:286. [PMID: 33054851 DOI: 10.1186/s13023-020-01573-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Dias MM, Moreno AS, Maia LSM, Nunes FL, Campos WN, Ferriani MPL, Silva WA Jr, Arruda LK. A cost-effective algorithm for diagnosis of hereditary angioedema with normal C1 inhibitor: Applying molecular approach to clinical practice. J Allergy Clin Immunol Pract 2020;8:419-421.e4. [PMID: 31319218 DOI: 10.1016/j.jaip.2019.06.041] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
196 Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother 2021:pvab018. [PMID: 33638977 DOI: 10.1093/ehjcvp/pvab018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Strainienė S, Jauniškis K, Savlan I, Pamedys J, Stundienė I, Liakina V, Valantinas J. Paraneoplastic Phenomena of Disseminated Intravascular Coagulopathy in Hepatic Angiosarcoma – Rare, Challenging and Fatal. Case Report and Literature Review. AML 2021;28:1. [DOI: 10.15388/amed.2021.28.2.1] [Reference Citation Analysis]
198 Wu AC, McMahon P, Lu C. Ending the Diagnostic Odyssey-Is Whole-Genome Sequencing the Answer? JAMA Pediatr 2020;174:821-2. [PMID: 32597967 DOI: 10.1001/jamapediatrics.2020.1522] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
199 Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. Value Health 2018;21:1033-42. [PMID: 30224106 DOI: 10.1016/j.jval.2018.06.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
200 Liu AC, Patel K, Vunikili RD, Johnson KW, Abdu F, Belman SK, Glicksberg BS, Tandale P, Fontanez R, Mathew OK, Kasarskis A, Mukherjee P, Subramanian L, Dudley JT, Shameer K. Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses. Brief Bioinform 2020;21:1182-95. [PMID: 31190075 DOI: 10.1093/bib/bbz059] [Reference Citation Analysis]
201 Johnson K, Saylor K, Guynn I, Hicklin K, Berg JS, Lich KH. A systematic review of the methodological quality of economic evaluations in genetic screening and testing for monogenic disorders. Genet Med 2021:S1098-3600(21)05358-2. [PMID: 34906467 DOI: 10.1016/j.gim.2021.10.008] [Reference Citation Analysis]
202 Levy MA, McConkey H, Kerkhof J, Barat-Houari M, Bargiacchi S, Biamino E, Bralo MP, Cappuccio G, Ciolfi A, Clarke A, DuPont BR, Elting MW, Faivre L, Fee T, Fletcher RS, Cherik F, Foroutan A, Friez MJ, Gervasini C, Haghshenas S, Hilton BA, Jenkins Z, Kaur S, Lewis S, Louie RJ, Maitz S, Milani D, Morgan AT, Oegema R, Østergaard E, Pallares NR, Piccione M, Pizzi S, Plomp AS, Poulton C, Reilly J, Relator R, Rius R, Robertson S, Rooney K, Rousseau J, Santen GWE, Santos-Simarro F, Schijns J, Squeo GM, St John M, Thauvin-Robinet C, Traficante G, van der Sluijs PJ, Vergano SA, Vos N, Walden KK, Azmanov D, Balci T, Banka S, Gecz J, Henneman P, Lee JA, Mannens MMAM, Roscioli T, Siu V, Amor DJ, Baynam G, Bend EG, Boycott K, Brunetti-Pierri N, Campeau PM, Christodoulou J, Dyment D, Esber N, Fahrner JA, Fleming MD, Genevieve D, Kerrnohan KD, McNeill A, Menke LA, Merla G, Prontera P, Rockman-Greenberg C, Schwartz C, Skinner SA, Stevenson RE, Vitobello A, Tartaglia M, Alders M, Tedder ML, Sadikovic B. Novel diagnostic DNA methylation episignatures expand and refine the epigenetic landscapes of Mendelian disorders. HGG Adv 2022;3:100075. [PMID: 35047860 DOI: 10.1016/j.xhgg.2021.100075] [Reference Citation Analysis]
203 Hiraide T, Yamoto K, Masunaga Y, Asahina M, Endoh Y, Ohkubo Y, Matsubayashi T, Tsurui S, Yamada H, Yanagi K, Nakashima M, Hirano K, Sugimura H, Fukuda T, Ogata T, Saitsu H. Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing. Clin Genet 2021;100:40-50. [PMID: 33644862 DOI: 10.1111/cge.13951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 González-Del Pozo M, Fernández-Suárez E, Martín-Sánchez M, Bravo-Gil N, Méndez-Vidal C, Rodríguez-de la Rúa E, Borrego S, Antiñolo G. Unmasking Retinitis Pigmentosa complex cases by a whole genome sequencing algorithm based on open-access tools: hidden recessive inheritance and potential oligogenic variants. J Transl Med 2020;18:73. [PMID: 32050993 DOI: 10.1186/s12967-020-02258-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
205 Lavelle TA, Feng X, Keisler M, Cohen JT, Neumann PJ, Prichard D, Schroeder BE, Salyakina D, Espinal PS, Weidner SB, Maron JL. Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions. Genet Med 2022;24:1349-61. [PMID: 35396982 DOI: 10.1016/j.gim.2022.03.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Kamalapathy P, Fonda Allen JS, Macri CJ, Lawrence AK, Regier DS, Rubio EI. Whole-exome sequencing for diagnosis of Peters-plus syndrome after prenatal diagnosis of recurrent low PAPP-A and multiple fetal anomalies in two consecutive pregnancies. J Neonatal Perinatal Med 2019;12:333-8. [PMID: 31476172 DOI: 10.3233/NPM-1854] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
207 Mitropoulou C, Litinski V, Kabakchiev B, Rogers S, P Patrinos G. PARC report: health outcomes and value of personalized medicine interventions: impact on patient care. Pharmacogenomics 2020;21:797-807. [PMID: 32635813 DOI: 10.2217/pgs-2019-0194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
208 Pook T, Freudenthal J, Korte A, Simianer H. Using Local Convolutional Neural Networks for Genomic Prediction. Front Genet 2020;11:561497. [PMID: 33281867 DOI: 10.3389/fgene.2020.561497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
209 Lu C, Greshake Tzovaras B, Gough J. A survey of direct-to-consumer genotype data, and quality control tool (GenomePrep) for research. Comput Struct Biotechnol J 2021;19:3747-54. [PMID: 34285776 DOI: 10.1016/j.csbj.2021.06.040] [Reference Citation Analysis]
210 Chen Z, Yan Z, Yu C, Liu J, Zhang Y, Zhao S, Lin J, Zhang Y, Wang L, Lin M, Huang Y, Li X, Niu Y, Wang S, Wu Z, Qiu G, Zhang TJ, Wu N; DISCO (Deciphering disorders Involving Scoliosis and COmorbidities) study group. Cost-effectiveness analysis of using the TBX6-associated congenital scoliosis risk score (TACScore) in genetic diagnosis of congenital scoliosis. Orphanet J Rare Dis 2020;15:250. [PMID: 32933559 DOI: 10.1186/s13023-020-01537-y] [Reference Citation Analysis]